|
JP2020195379A
|
|
Production method of cytotoxic t cells
|
|
JP2020184992A
|
|
Methods for detecting hla class i allele-lacking leukocytes
|
|
JP2020141664A
|
|
Data collection methods and kits for determining whether having malignant pancreatobiliary disease or not
|
|
JP2020125460A
|
|
Manufacturing method of stereoregular substituted polyacetylene having substituent on terminal
|
|
JP2021004859A
|
|
Scan type probe microscope and z drive device
|
|
JP2021004195A
|
|
Agent for preventing and treating fish disease
|
|
JP2020204501A
|
|
Self position estimation device of vehicle, and vehicle
|
|
JP2019214558A
|
|
Pharmaceutical composition for prevention or treatment of kidney damage
|
|
JP2020176905A
|
|
Ovarian cancer detection method and ovarian cancer therapeutic agent
|
|
JP2020173191A
|
|
Stress analysis method by diffraction ring
|
|
JP2020162565A
|
|
Bone three-dimensional structure derived from fat-derived stem cell sheet, and method of preparing the structure
|
|
JP2020076729A
|
|
Radiation dosimeter
|
|
JP2020152697A
|
|
Nucleotide excision repair inhibitor, tumor treatment enhancer and antitumor agent containing it
|
|
JP2020147551A
|
|
Immunopotentiator containing MHC class II restrictive epitope peptide
|
|
JP2020143260A
|
|
Method for producing polysaccharide derivative, and method for producing lignin derivative
|
|
JP2020143250A
|
|
Method for producing polysaccharide derivative, and method for producing lignin derivative
|
|
JP2020136199A
|
|
Plasma processing apparatus and plasma processing method
|
|
JP2020134272A
|
|
Method for measuring drug metabolism function
|
|
JP2020130013A
|
|
Determination method of onset risk of liver cancer, determination kit of onset risk of liver cancer, and pharmaceutical composition
|
|
JP2019137686A
|
|
Radiodiagnostic agent for bacterial infections
|
